catechin and Bowel Diseases, Inflammatory

catechin has been researched along with Bowel Diseases, Inflammatory in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, FY; Jiang, M; Sang, LX	1
Contreras, TC; Cremonini, E; Oteiza, PI; Ricciardi, E	1
Chen, Y; Lin, YZ; Song, YG	1

Reviews

1 review(s) available for catechin and Bowel Diseases, Inflammatory

Article	Year
Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease. Molecules (Basel, Switzerland), 2017, Mar-19, Volume: 22, Issue:3 Topics: Catechin; Cell Proliferation; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Inflammatory Bowel Diseases; Intercellular Junctions; Neutrophil Infiltration; Oxidative Stress	2017

Other Studies

2 other study(ies) available for catechin and Bowel Diseases, Inflammatory

Article	Year
(-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Archives of biochemistry and biophysics, 2015, May-01, Volume: 573 Topics: Anti-Inflammatory Agents; Antioxidants; Biological Transport; Caco-2 Cells; Catechin; Cell Differentiation; Enzyme Activation; Epithelial Cells; Fluoresceins; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Oxidants; Permeability; Tight Junctions; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein	2015
[Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis]. Zhonghua yi xue za zhi, 2007, Nov-13, Volume: 87, Issue:42 Topics: Animals; Blotting, Western; Catechin; Cyclooxygenase 2; Disease Models, Animal; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trinitrobenzenesulfonic Acid	2007

Article

Year

(-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.

Archives of biochemistry and biophysics, 2015, May-01, Volume: 573

Topics: Anti-Inflammatory Agents; Antioxidants; Biological Transport; Caco-2 Cells; Catechin; Cell Differentiation; Enzyme Activation; Epithelial Cells; Fluoresceins; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Oxidants; Permeability; Tight Junctions; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein

2015

[Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis].

Zhonghua yi xue za zhi, 2007, Nov-13, Volume: 87, Issue:42

Topics: Animals; Blotting, Western; Catechin; Cyclooxygenase 2; Disease Models, Animal; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trinitrobenzenesulfonic Acid

2007